Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Astrocytoma 8Glioblastoma 5Prostatic Neoplasms 4Neuroectodermal Tumors, Primitive 4Lymphoma, Non-Hodgkin 4Lung Neoplasms 3Recurrence 2Oligodendroglioma 2Neurocytoma 2Neoplasms 2Glioma 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Brain Neoplasms 2Waldenstrom Macroglobulinemia 1Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Somatostatinoma 1Small Intestine Cancer 1Small Cell Lung Carcinoma 1Sarcoma 1Salivary Gland Neoplasms 1Rhabdoid Tumor 1Pituitary Neoplasms 1Paranasal Sinus Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1

Interventions

Cisplatin 20Cetuximab 11Carboplatin 9Specimen Handling 8Radiotherapy 8Docetaxel 8Radiotherapy, Intensity-Modulated 7Magnetic Resonance Spectroscopy 71,2-diaminocyclohexaneplatinum II citrate 7Platinum 6Fluorouracil 6pembrolizumab 5Radiation 5toripalimab 4Paclitaxel 4cemiplimab 3X-Rays 3Surgical Procedures, Operative 3Celecoxib 3Biopsy 3130-nm albumin-bound paclitaxel 3Taxes 2Standard of Care 2Radiotherapy, Image-Guided 2Hydroxyurea 2Drug Therapy 2tislelizumab 1sodium thiosulfate 1sargramostim 1sacituzumab govitecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Laryngeal Neoplasms × antineoplaston AS 2-1 × Clear all
NCT00003489 2017-11-21

Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer

Burzynski Research Institute

Phase 2 Terminated
7 enrolled
Head & Neck

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Paranasal Sinus Neoplasms, Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡